Shen Y, Shenk T
Howard Hughes Medical Institute, Department of Molecular Biology, Princeton University, NJ 08544-1014.
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8940-4. doi: 10.1073/pnas.91.19.8940.
The p53 tumor suppressor gene product is a transcriptional regulatory protein. It activates transcription from promoters that contain a p53 DNA binding site but represses many promoters that lack its binding site. High-level expression of wild-type p53 can induce apoptosis in certain cell types, and this activity can be blocked by the adenovirus E1B 19-kDa oncoprotein or by the cellular Bcl-2 oncoprotein. Here we report that p53-mediated repression of promoters that lack a p53 binding site is abrogated by the E1B 19-kDa protein or Bcl-2 oncoprotein. In contrast, transcriptional activation by p53 still occurs in the presence of either protein. The fact that two oncoproteins capable of preventing p53-mediated apoptosis also block transcriptional repression by p53 raises the possibility that p53 might induce apoptosis, at least in part, by repressing transcription.
p53肿瘤抑制基因产物是一种转录调节蛋白。它可激活含有p53 DNA结合位点的启动子的转录,但会抑制许多缺乏其结合位点的启动子。野生型p53的高水平表达可在某些细胞类型中诱导凋亡,而腺病毒E1B 19 kDa癌蛋白或细胞Bcl-2癌蛋白可阻断这种活性。在此我们报告,E1B 19 kDa蛋白或Bcl-2癌蛋白可消除p53对缺乏p53结合位点的启动子的抑制作用。相反,在这两种蛋白存在的情况下,p53的转录激活仍会发生。两种能够阻止p53介导的凋亡的癌蛋白也能阻断p53的转录抑制作用,这一事实增加了p53至少部分通过抑制转录来诱导凋亡的可能性。